MasterSwitch Bio leverages master transcription therapy to rescue end stage organs. For End Stage Liver Disease with cirrhosis from MASH/metALD/ALD, our technology is a modified mRNA of HNF4α (hepatocyte nuclear factor-4 alpha), the master regulator of core functional health of hepatocytes.
© 2024 BioAdvance. All Rights Reserved. | Privacy Policy | Site by Loudmark
101 West Elm Street, Suite 330, Conshohocken, PA 19428 | (610) 230-0544